Literature DB >> 19934922

Preoperative radiotherapy is associated with worse functional results after coloanal anastomosis for rectal cancer.

Yann Parc1, Massarat Zutshi, Stéphane Zalinski, Rienhard Ruppert, Alois Fürst, Victor W Fazio.   

Abstract

PURPOSE: This study was designed to evaluate functional outcome in patients treated with preoperative radiotherapy after low anterior resection and a coloanal anastomosis for low rectal cancer.
METHODS: Functional outcome data from patients enrolled in a prospective randomized trial comparing 3 reconstructive procedures were evaluated with respect to administration of preoperative radiotherapy. Incontinence was assessed with a questionnaire on bowel function including the Fecal Incontinence Severity Index; sexual function was assessed with the Sexual Health Inventory for Men and a gender-specific questionnaire for women. Quality of life was assessed with SF-36 scores.
RESULTS: Of 364 patients enrolled, 153 (42%) had no radiotherapy or chemotherapy, and 211 (58%) had preoperative radiotherapy; 186 (51%) had chemotherapy in addition to radiotherapy. Comparison of irradiated vs. nonirradiated patients showed no significant differences in postoperative morbidity (29.9% vs. 35.3%; P = 0.27). Two-year follow-up of 297 patients showed greater impairment of bowel function in irradiated patients (n = 170) vs. nonirradiated patients (n = 127): e.g., mean number of daily bowel movements at 12 months, 4.2 +/- 3.5 vs. 3.5 +/- 2.6, P = 0.032; urgency, 85% vs. 67%, P = 0.002). Antidiarrheal use was significantly higher in irradiated patients vs. nonirradiated patients at 4 (P = 0.043), 12 (P = 0.002), and 24 (P = 0.001) months. Sexual Health Inventory for Men scores indicated poorer function in irradiated patients at 24 months (P = 0.039). Preoperative radiotherapy had no deleterious effects on quality of life. Multivariate analyses showed that negative effects of preoperative radiotherapy on urgency at 4 months (P = 0.002) and antidiarrheal use at 24 months were independent of reconstruction technique, but a positive effect of reconstruction with a J-pouch was still observed in patients who received radiotherapy.
CONCLUSION: Preoperative radiotherapy does not increase overall morbidity but is associated with poorer functional outcome after low anterior resection with coloanal anastomosis. Preoperative radiotherapy and the J-pouch are nonconfounding predictors of functional outcome up to 24 months after surgery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19934922     DOI: 10.1007/DCR.0b013e3181beb4d8

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  18 in total

Review 1.  Low anterior resection syndrome (LARS): cause and effect and reconstructive considerations.

Authors:  Y Ziv; A Zbar; Y Bar-Shavit; I Igov
Journal:  Tech Coloproctol       Date:  2012-10-18       Impact factor: 3.781

2.  MMP7 Modulation by Short- and Long-term Radiotherapy in Patients with Rectal Cancer.

Authors:  Christina Stene; Andrea Polistena; Alexander Gaber; Björn Nodin; Bianca Ottochian; Diya Adawi; Nicola Avenia; Karin Jirström; Louis Banka Johnson
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

Review 3.  Sphincter preservation for distal rectal cancer--a goal worth achieving at all costs?

Authors:  Jürgen Mulsow; Des C Winter
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

4.  To what extent is the low anterior resection syndrome (LARS) associated with quality of life as measured using the EORTC C30 and CR38 quality of life questionnaires?

Authors:  Juliane Kupsch; Matthias Kuhn; Klaus E Matzel; Joerg Zimmer; Olga Radulova-Mauersberger; Anja Sims; Helmut Witzigmann; Sigmar Stelzner
Journal:  Int J Colorectal Dis       Date:  2019-02-05       Impact factor: 2.571

Review 5.  Conversations for providers caring for patients with rectal cancer: Comparison of long-term patient-centered outcomes for patients with low rectal cancer facing ostomy or sphincter-sparing surgery.

Authors:  Lisa J Herrinton; Andrea Altschuler; Carmit K McMullen; Joanna E Bulkley; Mark C Hornbrook; Virginia Sun; Christopher S Wendel; Marcia Grant; Carol M Baldwin; Wendy Demark-Wahnefried; Larissa K F Temple; Robert S Krouse
Journal:  CA Cancer J Clin       Date:  2016-03-21       Impact factor: 508.702

6.  Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review.

Authors:  Ferdinando D'Amico; Steven D Wexner; Carolynne J Vaizey; Célia Gouynou; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2020-07-17       Impact factor: 4.623

7.  Routine defunctioning stoma after chemoradiation and total mesorectal excision: a single-surgeon experience.

Authors:  Shao-Chieh Lin; Po-Chuan Chen; Chung-Ta Lee; Hong-Ming Tsai; Peng-Chan Lin; Helen H W Chen; Yuan-Hwa Wu; Bo-Wen Lin; Wen-Pin Su; Jenq-Chang Lee
Journal:  World J Gastroenterol       Date:  2013-03-21       Impact factor: 5.742

8.  Does anastomotic leakage impair functional results and quality of life after laparoscopic sphincter-saving total mesorectal excision for rectal cancer? A case-matched study.

Authors:  Cécile Mongin; Léon Maggiori; Julie Agostini; Marianne Ferron; Yves Panis
Journal:  Int J Colorectal Dis       Date:  2014-01-31       Impact factor: 2.571

9.  Differences in short-term outcomes among patients undergoing IPAA with or without preoperative radiation: a National Surgical Quality Improvement Program analysis.

Authors:  Brittany E Wertzberger; Scott K Sherman; John C Byrn
Journal:  Dis Colon Rectum       Date:  2014-10       Impact factor: 4.585

10.  Comparative analysis of late functional outcome following preoperative radiation therapy or chemoradiotherapy and surgery or surgery alone in rectal cancer.

Authors:  Pietro Contin; Yakup Kulu; Thomas Bruckner; Martin Sturm; Thilo Welsch; Beat P Müller-Stich; Johannes Huber; Markus W Büchler; Alexis Ulrich
Journal:  Int J Colorectal Dis       Date:  2013-10-18       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.